Shikonin is a novel antagonist of prostaglandin E2 receptor 4 that targets myeloid-derived suppressor cells
Yang Wang(Kunming Medical University), Jiacheng He(Temple College), Weiqiang Lü(East China Normal University), Zun‐Ping Ke(Fudan University), Si Chen(University of Houston), Xian-Hua Lin(East China Normal University), Wenjuan Liu(University of California San Diego), Yuanjun Song(Shanghai Municipal Commission of Health and Family Planning), Xilong Wang(Capital Medical University), Bo Feng(Peking University), Weiwei Yu(East China Normal University), Wei Jiao(Fudan University), Naijipu Abuduaini(Shanghai Jiao Tong University)
Cited by 1
Related Papers
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
|EMBO Molecular Medicine|2020|110
Swimming Microrobot Optical Nanoscopy
|Nano Letters|2016|106
The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer
|Nature Immunology|2025|54
Role of GADD45A in myocardial ischemia/reperfusion through mediation of the JNK/p38 MAPK and STAT3/VEGF pathways
|International Journal of Molecular Medicine|2022|43
Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia
|Cell Death and Disease|2022|20